These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18269612)

  • 1. Tolerance of fondaparinux in patients with generalized contact dermatitis to heparin.
    Schindewolf M; Ludwig RJ; Wolter M; Himsel A; Zgouras D; Kaufmann R; Boehncke WH; Lindhoff-Last E
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):378-80. PubMed ID: 18269612
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed-type hypersensitivity to the ultra-low-molecular-weight heparin fondaparinux.
    Hohenstein E; Tsakiris D; Bircher AJ
    Contact Dermatitis; 2004 Sep; 51(3):149-51. PubMed ID: 15479206
    [No Abstract]   [Full Text] [Related]  

  • 3. Fondaparinux: a suitable alternative in cases of delayed-type allergy to heparins and semisynthetic heparinoids? A study of 7 cases.
    Jappe U; Juschka U; Kuner N; Hausen BM; Krohn K
    Contact Dermatitis; 2004 Aug; 51(2):67-72. PubMed ID: 15373846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of fondaparinux in a patient with antiphospholipid antibody syndrome and heparin-associated thrombocytopenia.
    Holtan SG; Knox SK; Tefferi A
    J Thromb Haemost; 2006 Jul; 4(7):1632-4. PubMed ID: 16839370
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials.
    Mehta SR; Boden WE; Eikelboom JW; Flather M; Steg PG; Avezum A; Afzal R; Piegas LS; Faxon DP; Widimsky P; Budaj A; Chrolavicius S; Rupprecht HJ; Jolly S; Granger CB; Fox KA; Bassand JP; Yusuf S;
    Circulation; 2008 Nov; 118(20):2038-46. PubMed ID: 18955665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fondaparinux and lepirudin as therapeutic alternatives in a disseminated eczematous skin reaction to low-molecular-weight heparin].
    Santiago Sánchez-Mateos DI; Eguren C; de Argila D; Sánchez-Pérez J
    Actas Dermosifiliogr; 2010 Jul; 101(6):556-8. PubMed ID: 20738979
    [No Abstract]   [Full Text] [Related]  

  • 8. Intolerance of fondaparinux in a patient allergic to heparins.
    Hirsch K; Ludwig RJ; Lindhoff-Last E; Kaufmann R; Boehncke WH
    Contact Dermatitis; 2004 Jun; 50(6):383-4. PubMed ID: 15274739
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypersensitivity to the pentasaccharide fondaparinux in patients with delayed-type heparin allergy.
    Utikal J; Peitsch WK; Booken D; Velten F; Dempfle CE; Goerdt S; Bayerl C
    Thromb Haemost; 2005 Oct; 94(4):895-6. PubMed ID: 16270653
    [No Abstract]   [Full Text] [Related]  

  • 10. Can heparin-induced thrombocytopenia be associated with fondaparinux use? A rebuttal.
    Elalamy I; Tribout B
    J Thromb Haemost; 2008 Jul; 6(7):1242-3; author reply 1243-6. PubMed ID: 19330935
    [No Abstract]   [Full Text] [Related]  

  • 11. Fondaparinux and the management of heparin-induced thrombocytopenia: the journey continues.
    Blackmer AB; Oertel MD; Valgus JM
    Ann Pharmacother; 2009 Oct; 43(10):1636-46. PubMed ID: 19737996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The complexities of anticoagulation in the antiphospholipid syndrome.
    Levy Y; Berla M
    Isr Med Assoc J; 2014 Jan; 16(1):54-6. PubMed ID: 24575508
    [No Abstract]   [Full Text] [Related]  

  • 13. Limitations of traditional anticoagulants.
    Hawkins D
    Pharmacotherapy; 2004 Jul; 24(7 Pt 2):62S-65S. PubMed ID: 15317400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate type hypersensitivity to low molecular weight heparins and tolerance of unfractioned heparin and fondaparinux.
    Harr T; Scherer K; Tsakiris DA; Bircher AJ
    Allergy; 2006 Jun; 61(6):787-8. PubMed ID: 16677252
    [No Abstract]   [Full Text] [Related]  

  • 15. Unexpected delayed-type hypersensitivity skin reactions to the ultra-low-molecular-weight heparin fondaparinux.
    Maetzke J; Hinrichs R; Schneider LA; Scharffetter-Kochanek K
    Allergy; 2005 Mar; 60(3):413-5. PubMed ID: 15679737
    [No Abstract]   [Full Text] [Related]  

  • 16. Fondaparinux for prevention of venous thromboembolism in high-risk trauma patients: a pilot study.
    Lu JP; Knudson MM; Bir N; Kallet R; Atkinson K
    J Am Coll Surg; 2009 Nov; 209(5):589-94. PubMed ID: 19854398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of fondaparinux (ARIXTRA) in a dialysis patient with symptomatic heparin-induced thrombocytopaenia type II.
    Haase M; Bellomo R; Rocktaeschel J; Ziemer S; Kiesewetter H; Morgera S; Neumayer HH
    Nephrol Dial Transplant; 2005 Feb; 20(2):444-6. PubMed ID: 15673695
    [No Abstract]   [Full Text] [Related]  

  • 18. The risk for cross-reactions after a cutaneous delayed-type hypersensitivity reaction to heparin preparations is independent of their molecular weight: a systematic review.
    Weberschock T; Meister AC; Bohrt K; Schmitt J; Boehncke WH; Ludwig RJ
    Contact Dermatitis; 2011 Oct; 65(4):187-94. PubMed ID: 21631519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fondaparinux in the treatment of acute coronary syndromes: evidence from OASIS 5 and 6.
    Karthikeyan G; Mehta SR; Eikelboom JW
    Expert Rev Cardiovasc Ther; 2009 Mar; 7(3):241-9. PubMed ID: 19296760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT).
    Rota E; Bazzan M; Fantino G
    Thromb Haemost; 2008 Apr; 99(4):779-81. PubMed ID: 18392338
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.